Hard to Treat Diseases (PKS. HTDS) and their Chinese subsidiary, Mellow Hope, have announced an update on the previously announced Chilean first order of 200,000 doses, valued at about $1.8 million. This will be the first shipment of the H1N1 vaccine to Chile. The company has reported that the first shipment is complete. However, the regulatory government permission to release the vaccines is the next step, which has no impact on HTDS.
MicroCap Insider is a web-based financial portal.
Sign Up for our Free Stock Newsletter
MicroCap Insider publishes a free penny stock newsletter providing stock alerts on companies positioned to deliver high-yield gains to investors.
HTDS Medical has found the best way to increase shareholder value, separate and apart from the operating performance of operating subsidiaries, by spinning off and distributing shares of its wholly owned subsidiaries in the form of a special dividend to the Company’s shareholders.
Sign Up for FREE. Investors interested in receiving small cap stock alerts through the penny stock newsletter published by MicroCap Insider can sign up for free by visiting our website.
About Us
MicroCap Insider is a leading penny stock web site with extensive experience in the OTC market, providing top stock picks, investing tips and exclusive research on small cap stocks on the verge of producing large financial gains.
Please click here to read the full disclaimer.
